Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 11
Submit an article Journal homepage
375
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Evolocumab for the treatment of hypercholesterolemia

Brian TomlinsonResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, China;Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong KongView further author information
,
Miao HuDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong KongView further author information
,
Yuzhen ZhangResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Paul ChanDivision of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, TaiwanCorrespondence[email protected]
View further author information
&
Zhong-Min LiuDepartment of Cardiac Surgery, Shanghai East Hospital, Tongji University, Shanghai, ChinaCorrespondence[email protected]
View further author information
Pages 1447-1461 | Received 16 May 2017, Accepted 04 Aug 2017, Published online: 16 Aug 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Brian Tomlinson, Elaine Chow, Paul Chan & Christopher Wai Kei Lam. (2021) An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1353-1361.
Read now
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok & Christopher Wai Kei Lam. (2021) Managing dyslipidemia in patients with Type 2 diabetes. Expert Opinion on Pharmacotherapy 22:16, pages 2221-2234.
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang & Christopher Wai Kei Lam. (2020) Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opinion on Pharmacotherapy 21:17, pages 2137-2151.
Read now

Articles from other publishers (2)

Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok & Christopher Wai Kei Lam. (2021) Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia. Endocrinology and Metabolism 36:2, pages 279-295.
Crossref
Sneha Srinivasan. (2019) Use of the PCSK9 inhibitor, evolocumab, in patients with heterozygous familial hypercholesterolemia. MOJ Public Health 8:5, pages 156-160.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.